| Effect | None |
| Trial Design | Double blind |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 25 |
| Gender | Male |
| Age Range | 18-29, 30-44, 45-64 |
| Body Types | Trained, Average |
Supplementation of a product with very similar composition to EPs-7630 at 30 drops thrice daily for a month to male marathon runners without allergic disorders and maintaining their normal training protocols noted an increase in post-exercise salivary IgA relative to placebo and the exercise induced increases in IL-6 and IL-15 were prevented with supplementation.